Intranasal Oxytocin Treatment for Alcohol Use Disorders: A Randomized, Placebo-Controlled Trial
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2019
Price : $35 *
At a glance
- Drugs Oxytocin (Primary)
- Indications Alcohol-related disorders
- Focus Therapeutic Use
- Acronyms OT-ETOH-4
- 11 Nov 2019 Status changed from suspended to withdrawn prior to enrolment.
- 17 Jul 2019 Status changed from not yet recruiting to suspended.
- 17 Jul 2019 Planned End Date changed from 1 Sep 2021 to 1 Sep 2022.